If You Invested in Landos Biopharma, Inc. (LABP)
See the LABP overviewWhat $1,000 or $10,000 in LABP Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Feb 4, 2021 |
|---|---|---|---|---|
| $1,000 | $6,970 +597% | — | — | $191 -81% |
| $10,000 | $69,696 +597% | — | — | $1,911 -81% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-05-23. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for LABP$1,000 Investment Over Time
LABP vs S&P 500Year-by-Year Returns
LABP annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021Feb 4, 2021 to Dec 31, 2021 | $120.00 | $48.00 | -60.0% | -60.0% |
| 2022 | $48.00 | $5.00 | -89.6% | -95.8% |
| 2023 | $5.00 | $3.66 | -26.8% | -97.0% |
| 2024Dec 29, 2023 to May 23, 2024 | $3.66 | $22.93 | +526.5% | -80.9% |
About Landos Biopharma, Inc.
NASDAQ
Frequently Asked Questions
Landos Biopharma, Inc. investment returns
How much was $1,000 invested in Landos Biopharma, Inc. worth at its last close?
If you invested $1,000 in Landos Biopharma, Inc. (LABP) 1 year before its last close, on 2023-05-23, your investment was worth $6,970 on 2024-05-23, a +597.0% price return without dividends, growing at a compounded rate of 594.2% per year (CAGR).
Has Landos Biopharma, Inc. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare LABP performance over available time periods.
What is Landos Biopharma, Inc.'s average annual return?
The compound annual growth rate (CAGR) of LABP’s share price over the 1 year to May 23, 2024 is 594.2%, without dividends. Individual years vary a great deal, and LABP’s best recent full year was 2023 (-26.8%) while the worst was 2022 (-89.6%).
For informational and educational purposes only, not investment advice.
